MeSH tree: D03.633.100.473.402.613
A study of 19 patients with treatment-resistant depression treated with psilocybin in Switzerland found psilocybin was associated with a significant reduction in depression symptoms. The study is published in The Lancet Regional ...
Jun 2, 2026
0
6
A single dose of psilocybin, the active compound in magic mushrooms, reduces nerve pain for up to a month and makes a widely used painkiller work more effectively, University of Reading research has found.
May 22, 2026
0
33
A single dose of psilocybin eased symptoms of depression within days, with benefits lasting for more than three months compared to placebo, our new study has found.
May 22, 2026
0
10
A single dose of the psychedelic substance psilocybin can provide rapid relief from depressive symptoms—within just a few days. This is shown by the first randomized, double-blind study in Sweden of psilocybin for depression. ...
May 15, 2026
0
62
Cocaine addiction treatment has found a surprising new contender in the highly regulated substance psilocybin, a naturally occurring psychedelic compound found in mushroom species popularly known as magic mushrooms or shrooms. ...
Psychedelic-assisted therapy is the subject of renewed focus. It involves using psilocybin—a substance found in psychoactive fungi—or LSD to treat mental disorders. Numerous studies are currently underway, with talk rife ...
May 7, 2026
0
10
More than 200 mushrooms—primarily those belonging to a genus of gilled mushrooms called Psilocybe—contain the psychoactive compound psilocybin. In the brain of mammals, this chemical can bind to serotonin receptors and influence ...
May 7, 2026
0
17
Researchers at UC San Francisco and Imperial College London have shown that a single dose of psilocybin, the psychedelic compound found in magic mushrooms, causes likely anatomical brain changes that last for up to a month ...
May 5, 2026
0
471
Researchers from University of California San Diego have found that microdosing—taking very small amounts of psychoactive substances—is more common among U.S. adults than previously recognized, with cannabis leading by a ...
May 4, 2026
0
11
A new study from the University of Victoria (UVic) has identified a segment of traumatic brain injury survivors who are using psychedelics to self-medicate for cognitive, mood and somatic symptoms such as headaches. In a ...
Apr 27, 2026
0
6
